open-access-imgOpen AccessPseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
Chunjin Ding,
Rundong He,
Jinghan Zhang,
Zhan Dong,
Jun Wu
Publication year2021
Publication title
cancer cell international
Resource typeJournals
Background Pseudogenes played important roles in tumorigenesis, while there are nearly no reports about the expression and roles of HSPA7 in the cancer. Methods Firstly, we used Logistic regression, the KS test, the GEPIA database, UALCAN database and qRT-PCR to analyze the expression level of HSPA7 in KIRC, then we used the Cox regression and the Kaplan–Meier curve to analyze the overall survival (OS) of KIRC patients with different Clinico-pathological parameters. Thirdly, we used the multivariate Cox analysis of influencing factors to compare the correlation between the HSPA7 expression level and the clinical parameters. Finally, we used multi-GSEA analysis and the Tumor Immunoassay Resource (TIMER) database to explore the functional role of HSPA7 in KIRC Results The HSPA7 is highly expressed in KIRC tumor tissues, and its expression is related to clinico-pathological features and survival in KIRC patients. GSEA analysis displayed the high expression of HSPA7 in KIRC were related to several tumor-related and immune-related pathways. With the TIMER database analysis we showed that HSPA7 levels were correlated with the CD4 + T cells, neutrophils and Dendritic Cell. Conclusions Our study showed that HSPA7 is very important in the tumor progression and may act as a poor prognostic biomarker for KIRC tumor by modulating immune infiltrating cells. Supplementary Information The online version contains supplementary material available at 10.1186/s12935-021-02141-1.
Subject(s)adrenocortical carcinoma , biology , biomarker , cancer research , genetics , immune system , immunoediting , immunology , immunotherapy , medicine , oncology , proportional hazards model
Keyword(s) Kidney Renal Clear Cell Carcinoma (KIRC) , HSPA7 , Immune , Prognostic biomarker , Tumor
SCImago Journal Rank1.322

Seeing content that should not be on Zendy? Contact us.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here